Usefulness of SYNTAX score II in complex percutaneous coronary interventions in the setting of acute coronary syndrome

Wijns, 2010, Guidelines on myocardial revascularization, Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277 Levine, 2011, ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions, J Am Coll Cardiol, 58, 44, 10.1016/j.jacc.2011.08.007 Caixeta, 2014, Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial), Am J Cardiol, 113, 203, 10.1016/j.amjcard.2013.08.035 Farooq, 2013, Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II, Lancet, 381, 639, 10.1016/S0140-6736(13)60108-7 Chen, 2013, The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study, JACC Cardiovasc Interv, 6, 1233, 10.1016/j.jcin.2013.08.006 Campos, 2014, Predictive performance of SYNTAX Score II in patients with left main and multivessel coronary artery disease, Circ J, 78, 1942, 10.1253/circj.CJ-14-0204 Steg, 2012, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 Hamm, 2011, Eur Heart J, 32, 2999, 10.1093/eurheartj/ehr236 Version 2.11 of the SYNTAX Score calculator. <http://www.syntaxscore.com/> [Date accessed XX]. Thygesen, 2012, Third universal definition of myocardial infarction, Circulation, 126, 2020, 10.1161/CIR.0b013e31826e1058 Cutlip, 2007, Clinical end points in coronary stent trials: a case for standardized definitions, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313 Hess, 2013, Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS, Eur Heart J Acute Cardiovasc Care, 2, 246, 10.1177/2048872612474922 Serruys, 2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056/NEJMoa0804626 Chieffo, 2012, Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment, JACC Cardiovasc Interv, 5, 718, 10.1016/j.jcin.2012.03.022 Latib, 2009, Clinical outcomes after unrestricted implantation of everolimus-eluting stents, JACC Cardiovasc Interv, 2, 1219, 10.1016/j.jcin.2009.09.014 Tamburino, 2008, Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents, Catheter Cardiovasc Interv, 72, 448, 10.1002/ccd.21666 Farooq, 2013, Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score, Circulation, 128, 141, 10.1161/CIRCULATIONAHA.113.001803 Rodriguez, 1993, Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group, J Am Coll Cardiol, 22, 1060, 10.1016/0735-1097(93)90416-X Faxon, 1992, The degree of revascularization and outcome after multivessel coronary angioplasty, Am Heart J, 123, 854, 10.1016/0002-8703(92)90687-Q Witberg, 2015, The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions, Catheter Cardiovasc Interv, 86, 3, 10.1002/ccd.25753 Patel, 2012, J Am Coll Cardiol, 2012, 857, 10.1016/j.jacc.2011.12.001 Farkouh, 2012, Strategies for multivessel revascularization in patients with diabetes, N Engl J Med, 367, 2375, 10.1056/NEJMoa1211585 Boukhris, 2015, Invasive assessment modalities of unprotected left main stenosis, J Saudi Heart Assoc, 27, 109, 10.1016/j.jsha.2014.04.006 Capodanno, 2013, Beyond the SYNTAX score–advantages and limitations of other risk assessment systems in left main percutaneous coronary intervention, Circ J, 77, 1131, 10.1253/circj.CJ-12-1613 Xu, 2014, Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention, JACC Cardiovasc Interv, 7, 1128, 10.1016/j.jcin.2014.05.018 Obeid, 2015, Prognostic significance of syntax score ii in patients presenting with acute coronary syndrome undergoing percutaneous intervention, J Am Coll Cardiol, 65, 45, 10.1016/S0735-1097(15)60045-6 Campos, 2015, Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5433 patients enrolled in contemporary coronary stent trials, Int J Cardiol, 187, 111, 10.1016/j.ijcard.2015.03.248